Skinska Pharmaceutica Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.35 Cr
- Revenue Growth -29.15%
- Profit Growth -94.72%
- Ebitda -8.80%
- Net Worth 2.99%
- Total Assets -0.40%
About Skinska Pharmaceutica
Skinska Pharmaceutica Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2018 (Six years and two months 30 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.35 Cr.
Sindhupriya Chintalapudi and Rambabu Chintalapudi serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2018PTC317031
-
Company No.
317031
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Nov 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Skinska Pharmaceutica Private Limited offer?
Skinska Pharmaceutica Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Hand Sanitizers & Personal Hygiene, Bath Soaps, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Body Cream, Ayurvedic & Herbal Extracts, Herbal Extracts, Soaps, Detergent Powder & Cakes.
Who are the key members and board of directors at Skinska Pharmaceutica?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sindhupriya Chintalapudi
|
Director | 13-Nov-2018 | Current |
|
Rambabu Chintalapudi
|
Director | 01-Jun-2020 | Current |
Financial Performance of Skinska Pharmaceutica.
Skinska Pharmaceutica Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.15% decrease. The company also saw a substantial fall in profitability, with a 94.72% decrease in profit. The company's net worth moved up by a moderate rise of 2.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skinska Pharmaceutica?
In 2022, Skinska Pharmaceutica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Skinska Naturals Private LimitedSindhupriya Chintalapudi and Rambabu Chintalapudi are mutual person
Charges (Loans)
₹13.46 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 2021 | Hdfc Bank Limited | ₹1.96 M | Open |
| 16 Apr 2021 | Hdfc Bank Limited | ₹1.15 Cr | Open |
How Many Employees Work at Skinska Pharmaceutica?
Skinska Pharmaceutica has a workforce of 38 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skinska Pharmaceutica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skinska Pharmaceutica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
